Morning Overview on MSN
A 40-year pillar of heart attack care just crumbled — a massive international trial found the beta blockers millions take after a heart attack offered no real benefit
For roughly four decades, the playbook after a heart attack has included a near-automatic prescription: beta-blockers, taken ...
Morning Overview on MSN
A daily multivitamin slowed all five epigenetic aging clocks in a randomized trial — people who started biologically older benefited most
Among nearly 1,000 older adults randomly assigned to take either a daily multivitamin or a placebo for two years, those in ...
Phase 3b ENCORE data assess inhaled amikacin in MAC lung disease. Read more on efficacy, safety, and patient-reported ...
MedPage Today on MSN
Trial Casts Doubt on Antibiotics for Refractory Low Back Pain
Now it's up to clinicians to sort out conflicting evidence ...
Concordance needs to be earned, not assumed Although randomised controlled trials remain the reference standard for assessing ...
In the 1940s, medical researchers began using randomized controlled trials to assess the efficacy of health interventions. In ...
GIP, and glucagon drug shows that it may be too effective, while causing a whopping 11% of participants at the highest dose to drop out because of the severity of the side effects. In Optimizer, ...
Idiopathic normal-pressure hydrocephalus is a neurologic disorder characterized by impaired gait, balance, cognition, and bladder control in older adults. The disorder is treated with shunt surgery, ...
Evidence-based practices for reducing opioid-related overdose deaths include overdose education and naloxone distribution, the use of medications for the treatment of opioid use disorder, and ...
SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers While the addition of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results